| Quote | Spy CELG NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
Searching For Growth And Value In Biotech
AMGN GENZ CELG BIIB GILD Linked by Investopedia Stock Analysis - March 09, 11:27AM from (stocks.investopedia.com) With health care reform ever present in the news, what are the prospects for biotech firms? more ...
Celgene Reports Inline Q4 EPS of $0.62, Guides FY10 Below
CELG Linked by StreetInsider - January 28, 07:37AM from (www.streetinsider.com) more ...
Celgene Reports Record Fourth Quarter and Full Year 2009 Product Sales and Operating Income
CELG Linked by BusinessWire - January 28, 07:30AM from (www.businesswire.com) Celgene Corporation (NASDAQ: CELG): 2009 Fourth Quarter Financial Results Year-Over-Year: Non-GAAP Total Revenue Increased more ...
Celgene Corporation to Announce Fourth Quarter and Full-Year 2009 Results on January 28, 2010
CELG Linked by BusinessWire - January 19, 07:30AM from (www.businesswire.com) Celgene Corporation (NASDAQ: CELG) senior management will host a conference call and live audio webcast on Thursday, January more ...
Reuters BreakingViews: At Genzyme, a Long View
GENZ CELG MEDI BIIB BARE Linked by NYTimes - January 17, 10:11PM from (feeds.nytimes.com) Investors shouldn’t put Genzyme on the block. The company should divest its noncore businesses and fix its manufacturing more ...
Celgene Completes Acquisition of Gloucester Pharmaceuticals
CELG Linked by BusinessWire - January 15, 07:30AM from (www.businesswire.com) Celgene Corporation (NASDAQ: CELG) today announced it has closed its acquisition of Gloucester Pharmaceuticals following more ...
Flying With Airlines, Apple And Google
AMR BA DAL EK F IBM MRK BAC XRX CAL AAPL LCC MSFT CELG GS NOK COF YHOO RIMM RIG CRM GOOG Linked by Forbes - January 14, 10:13AM from (www.forbes.com) Airlines are the antithesis of great growth stocks, but why fight the market when it rewards speculation? more ...
Celgene remains in an uptrend
CELG Linked by BloggingStocks - December 21, 05:00PM from (www.bloggingstocks.com) Celgene Corp's (CELG) stock has encountered resistance at $58, but I'm nevertheless reiterating my buy rating for the company's more ...
Celgene Blood Cancer Drug Found Effective
CELG Linked by BloggingStocks - December 18, 01:00PM from (www.bloggingstocks.com) Celgene (CELG - option chain) shares are rising today after a late-stage study of its blood cancer drug Revlimid was found more ...
Top 10 Analyst Upgrades, Downgrades, Initiations
NTRS BP MU EMC CELG POT NTAP RIMM AOL Linked by 24/7 Wall St. - December 18, 08:01AM from (247wallst.com) These are this Friday's top analyst upgrades, downgrades, and initiations seen in Wall Street research calls: AOL Inc. (NYSE: AOL) Started as Neutral at Goldman Sachs. more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2010 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.
|
|